Body composition differences in normal weight, obese-overweight and anorexic adolescents: Role of adipocytokines

Medicine and Sport Science

Volumn 55, Issue , 2010, Pages 32-42

  Ondrak, Kristin S ^a   Hackney, Anthony C ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANOREXIA; ARTICLE; BLOOD; BODY COMPOSITION; HUMAN; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOKINES; ADOLESCENT; ANOREXIA; BODY COMPOSITION; HUMANS; INTERLEUKIN-6; OVERWEIGHT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878374260     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000321970     Document Type: Article

References (43)

1. Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli SM, Jeammet P: Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology 2003;28:229-249.
2. Dostalova I, Kunesova M, Duskova J, Papezova H, Nedvidkova J: Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition 2006;22: 977-983.
3. Gualilo O, Gonzalez-Juanatey JR, Lago F: The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.Trends Cardiovas Med 2007;17:275-283.
4. Holden RJ, Pakula IS: The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses 1996;47:423-438.
5. Li M, Fisette A, Zhao X-Y, Deng J-Y, Mi J, Cianflone K: Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes (Lond) 2009;33:424-439.
6. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS: Adiponectinacts in the brain to decrease body weight. Nat Med 2004;10:524-529.
7. Stringer DM, Sellers EA, Burr LL, Taylor CG: Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus. Pediatr Diabetes 2009;10:269-277.
8. Andersen AE: Eating disorders in males; in Brownell KD, Fairburn CG (eds): Eating Disorders and Obesity: a Comprehensive Handbook. New York, Guilford Press, 1995, pp 177-187.
9. American Psychiatric Association Work Group on Eating Disorders: Practice guideline for the treatment of patients with eating disorders (revision). Am J Psychiatry 2000;157(1 suppl):1-39.
10. Wong S, Pinkney J: Role of cytokines in regulating feeding behavior. Current Drug Targets 2004;5:251-263.
11. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology 2007;32:2087-2102.
12. World Health Organization: Programmes and Projects: Global Strategy on Diet, Physical Activity and Health - Childhood Overweight and Obesity, 2009.
13. Lago F, Dieguez C, Gómez-Reino J, Gualillo O: Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007;3:716-724. (Pubitemid 350187017)
14. Moschos S, Chan JL, Mantzoros CS: Leptin and reproduction: a review. Fertil Steril 2002;77:433-444.
15. Argente J, Barrios V, Chowen JA, Sinha MK, Considine RV: Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa. J Pediatr 1997;131:833-838.
16. Gerber M, Boettner A, Seidel B, Lammert A, Bär J, Schuster E, Thiery J, Kiess W, Kratzsch J: Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005;90:4503-4509.
17. Torres MD, Tormo MA, Campillo C, Carmona MI, Torres M, Reymundo M, García P, Campillo JE: Etiologic and cardiovascular risk factors in obese children from extremadura in Spain: their relationship with insulin resistance and plasma adipocytokine levels. Rev Esp Cardiol 2008;61:923-929.
18. Misra M, Miller KK, Almazan C, Ramaswamy K, Aggarwal A, Herzog DB, Neubauer G, Breu J, Klibanski A: Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 2004;89:3486-3495.
19. Misra M, Miller KK, Kuo K, Griffin K, Stewart V, Hunter E, Herzog DB, Klibanski A: Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005;289:E373-381.
20. Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M, Loewenthal R, Yissachar E, Hemi R, Kanety H: Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007;92:1843-1847.
21. Misra M, Miller KK, Tsai P, Stewart V, End A, Freed N, Herzog DB, Goldstein M, Riggs S, Klibanski A: Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. J Pediatr 2006; 149:763-769.
22. Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M: Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003;58:22-29.
23. Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M: Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol (Oxf) 2007;67:674-678.
24. Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, Papezová H, Haluzik M: Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005;90:1366-1370. (Pubitemid 40463989)
25. Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, De Giacomo P, Giorgino R, De Pergola G: Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003;88:1748-1752.
26. Vaisman N, Hahn T, Karov Y, Sigler E, Barak Y, Barak V: Changes in cytokine production and impaired hematopoiesis in patients with anorexia nervosa: the effect of refeeding. Cytokine 2004;26: 255-261.
27. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, Shirahata A, Taniyama M: Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003;11:1072-1079.
28. Misra M, Miller KK, Cord J, Prabhakaran R, Herzog DB, Goldstein M, Katzman DK, Klibanski A: Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007;92:2046-2052.
29. Rubin DA, McMurray RG, Harrell JS, Hackney AC, Haqq AM: Do surrogate markers for adiposity relate to cytokines in adolescents? J Investig Med 2008;56: 786-792.
30. Shin JY, Kim SY, Jeung MJ, Eun SH, Woo CW, Yoon SY, Lee KH: Serum adiponectin, c-reactive protein and TNF-α levels in obese Korean children. J Pediatr Endoocrinol Metab 2008;21:23-29.
31. Reinehr T, Roth C, Menke T, Andler W: Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-3794.
32. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L, Cooper DM: Adipocytokines, body composition, and fitness in children. Pediatr Res 2003;53:148-152.
33. Haluzíková D, Dostálová I, Kaválková P, Roubícek T, Mráz M, Papezová H, Haluzík M: Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009;58: 577-581.
34. Krízová J, Dolinková M, Lacinová Z, Sulek S, Dolezalová R, Housová J, Krajícková J, Haluzíková D, Bosanská L, Papezová H, Haluzík M: Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res 2008;57:539-546.
35. Hoene M, Weigert C: The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 2008;9:20-29.
36. Hackney AC, Battaglini CL, Evans ES: Cortisol, stress and adaptation during exercise training. Educ Phys Training Sport (Biomed Sci) 2008;3:34-41.
37. Jansson J, Wallenius K, Wernstedt I, Ohlsson C, Dickson SL, Wallenius V: On the site mechanism of action of the anti-obesity effects of interleukin-6. Grow Horm IGF Res 2003;13:S28-S32.
38. Nova E, Gómez-Martínez S, Morandé G, Marcos A: Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa. Br J Nutr 2002;88:183-188.
39. Brambilla F, Monti D, Franceschi C: Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa. Psychiatry Res 2001;103:107-114.
40. Pomeroy C, Eckert E, Hu S, Eiken B, Mentink M, Crosby RD, Chao CC: Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa. Biol Psychiatry 1994;36:836-839.
41. Raymond NC, Dysken M, Bettin K, Eckert ED, Crow SJ, Markus K, Pomeroy C: Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord 2000;28:293-302.
42. Idriss HT, Naismith JH: TNF alpha and the TNF receptor superfamily: structure-function relationship( s). Microsc Res Tech 2000;50:184-195.
43. Moon YS, Kim DH, Song DK: Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 2004;53:863-867.